{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:03:28Z","timestamp":1789603408474,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014358","name":"Second Affiliated Hospital of Soochow University","doi-asserted-by":"publisher","award":["XKTJ-TD202410"],"award-info":[{"award-number":["XKTJ-TD202410"]}],"id":[{"id":"10.13039\/501100014358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2022-RC350-04"],"award-info":[{"award-number":["2022-RC350-04"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372002"],"award-info":[{"award-number":["82372002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502399"],"award-info":[{"award-number":["82502399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82525067"],"award-info":[{"award-number":["82525067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22507148"],"award-info":[{"award-number":["22507148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","award":["3332025068"],"award-info":[{"award-number":["3332025068"]}],"id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","award":["3332025193"],"award-info":[{"award-number":["3332025193"]}],"id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","award":["3332025153"],"award-info":[{"award-number":["3332025153"]}],"id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","award":["3332025067"],"award-info":[{"award-number":["3332025067"]}],"id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014883","name":"China National Nuclear Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L248087"],"award-info":[{"award-number":["L248087"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L234044"],"award-info":[{"award-number":["L234044"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7252206"],"award-info":[{"award-number":["7252206"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L246051"],"award-info":[{"award-number":["L246051"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M773592"],"award-info":[{"award-number":["2025M773592"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2024-12M-ZH-009"],"award-info":[{"award-number":["2024-12M-ZH-009"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-026"],"award-info":[{"award-number":["2021-I2M-1-026"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-3-001"],"award-info":[{"award-number":["2021-I2M-3-001"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2023-I2M-2-006"],"award-info":[{"award-number":["2023-I2M-2-006"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2025-I2M-XHXX-098"],"award-info":[{"award-number":["2025-I2M-XHXX-098"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2025-I2M-XHJC-026"],"award-info":[{"award-number":["2025-I2M-XHJC-026"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.apsb.2025.12.028","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:17:31Z","timestamp":1766535451000},"page":"5553-5565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of galectin-3 targeted radioimmunoligands for cancer theranostics"],"prefix":"10.1016","volume":"16","author":[{"given":"Siqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4451-3380","authenticated-orcid":false,"given":"Quan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiushuang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0679-270X","authenticated-orcid":false,"given":"Pingping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2549-629X","authenticated-orcid":false,"given":"Kuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.12.028_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2025.12.028_bib2","doi-asserted-by":"crossref","first-page":"CMO","DOI":"10.4137\/CMO.S29462","article-title":"Galectin-3 as a potential target to prevent cancer metastasis","volume":"9","author":"Ahmed","year":"2015","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.apsb.2025.12.028_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2014.01.019","article-title":"Galectin-3 in cancer","volume":"431","author":"Song","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.apsb.2025.12.028_bib4","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1158\/0008-5472.CAN-15-3046","article-title":"Noninvasive in vivo imaging and biologic characterization of thyroid tumors by immunoPET targeting of galectin-3","volume":"76","author":"D'Alessandria","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.12.028_bib5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/JLB.5MR0822-673R","article-title":"Galectin-3 as a biomarker in breast neoplasms: mechanisms and applications in patient care","volume":"112","author":"Niang","year":"2022","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.apsb.2025.12.028_bib6","article-title":"Galectin-3 as a marker and potential therapeutic target in breast cancer","volume":"9","author":"Glynn","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2025.12.028_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00432-012-1178-2","article-title":"The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma","volume":"138","author":"Xie","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.apsb.2025.12.028_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002371","article-title":"Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor","volume":"9","author":"Curti","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2025.12.028_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2025.12.028_bib10","first-page":"255","article-title":"Radiotheranostics in oncology: making precision medicine possible","volume":"73","author":"Aboagye","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2025.12.028_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.12.028_bib12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41571-022-00652-y","article-title":"Radiotheranostics in oncology: current challenges and emerging opportunities","volume":"19","author":"Bodei","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2025.12.028_bib13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.apsb.2024.07.006","article-title":"Enhanced radiotheranostic targeting of integrin \u03b15\u03b21 with PEGylation-enabled peptide multidisplay platform (PEGibody): a strategy for prolonged tumor retention with fast blood clearance","volume":"15","author":"Zhang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.028_bib14","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1007\/s00259-022-05711-1","article-title":"Galectin expression detected by 68Ga-galectracer PET as a predictive biomarker of radiotherapy resistance","volume":"49","author":"Lu","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.apsb.2025.12.028_bib15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2967\/jnumed.107.048751","article-title":"111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors","volume":"49","author":"Kumar","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.apsb.2025.12.028_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/ami.2011.11001","article-title":"Evaluation of 64Cu-DOTA- and 64Cu-CBTE2A-galectin-3 peptide as a PET radiotracer for breast carcinoma","volume":"1","author":"Kumar","year":"2011","journal-title":"Adv Mol Imag"},{"key":"10.1016\/j.apsb.2025.12.028_bib17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/acs.jmedchem.9b01692","article-title":"In vivo veritas: 18F-radiolabeled glycomimetics allow insights into the pharmacological fate of galectin-3 inhibitors","volume":"63","author":"Bratteby","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.12.028_bib18","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3390\/pharmaceutics14112504","article-title":"The synthesis and preclinical investigation of lactosamine-based radiopharmaceuticals for the detection of galectin-3-expressing melanoma cells","volume":"14","author":"Gyuricza","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2025.12.028_bib19","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1021\/acs.chemrev.9b00738","article-title":"ImmunoPET: concept, design, and applications","volume":"120","author":"Wei","year":"2020","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2025.12.028_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00259-024-06907-3","article-title":"Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: applications in PET imaging of multiple myeloma","volume":"52","author":"Ma","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.apsb.2025.12.028_bib21","article-title":"Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3","volume":"3","author":"Boswell","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2025.12.028_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2967\/jnumed.118.219105","article-title":"Galectin-3 targeting in thyroid orthotopic tumors opens new ways to characterize thyroid cancer","volume":"60","author":"De Rose","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.apsb.2025.12.028_bib23","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.1038\/s41598-021-86641-0","article-title":"Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo","volume":"11","author":"Peplau","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.12.028_bib24","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.7150\/thno.50247","article-title":"Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (89Zr)-DFO- Galectin3-F(ab')2 mAb","volume":"11","author":"Varasteh","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.12.028_bib25","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1021\/acs.molpharmaceut.3c00382","article-title":"Linear peptide-based PET tracers for imaging PD-L1 in tumors","volume":"20","author":"Zhang","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2025.12.028_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","article-title":"The regulation of inflammation by galectin-3","volume":"230","author":"Henderson","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.apsb.2025.12.028_bib27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cellbi.2006.11.036","article-title":"Expression and immunohistochemical localization of galectin-3 in various mouse tissues","volume":"31","author":"Kim","year":"2013","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.apsb.2025.12.028_bib28","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2019.11.296","article-title":"Effects of belapectin, an inhibitor of galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension","volume":"158","author":"Chalasani","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2025.12.028_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/17512433.2021.1894127","article-title":"Review of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis","volume":"14","author":"Al Attar","year":"2021","journal-title":"Expet Rev Clin Pharmacol"},{"key":"10.1016\/j.apsb.2025.12.028_bib30","article-title":"Alzheimer's disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.apsb.2025.12.028_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216879","article-title":"Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth","volume":"591","author":"Rivera-Ramos","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2025.12.028_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/TUB-230002","article-title":"Co-expression of galectin-3 and vimentin in triple negative breast cancer cells promotes tumor progression, metastasis and survival","volume":"45","author":"Jeethy","year":"2023","journal-title":"Tumour Biol"},{"key":"10.1016\/j.apsb.2025.12.028_bib33","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1021\/acs.jmedchem.0c01180","article-title":"Small-molecule drug discovery in triple negative breast cancer: current situation and future directions","volume":"64","author":"Liao","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.12.028_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.gastro.2024.03.007","article-title":"Genetic deletion of galectin-3 inhibits pancreatic cancer progression and enhances the efficacy of immunotherapy","volume":"167","author":"Yang","year":"2024","journal-title":"Gastroenterology"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525008366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525008366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:19:49Z","timestamp":1789600789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525008366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211383525008366"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.028","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of galectin-3 targeted radioimmunoligands for cancer theranostics","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}